Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05502029 · ClinicalTrials.gov registry record · NA

Translating Anesthesia Care Throughout

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT05502029 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 22 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05502029, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

Patients with limited English proficiency (LEP) are at significant risk of receiving care different from those who are English proficient. Through Translating Anesthetic Care Throughout (TACT), the investigators aim to reduce the disparities experienced by participants with LEP undergoing anesthesia by continuing language translation from the preoperative area into the operating room, where participants will be better able to understand what is happening in an otherwise foreign environment. At this time, some participants receive translation in the preoperative area using an interpreter. No further translation is provided beyond the preoperative area unless there is a provider with language concordance or interpretation skills within the perioperative team. The investigators plan to study how extended translation changes a participant's understanding of and feelings about the perioperative period. Supporting language translation for LEP participants from the preoperative area into their operating room (OR) experience will enable providers to better understand how to care for participants from different cultural and language backgrounds and will help us understand how to better serve our community at large. The investigators hypothesize that participants who receive continual translation will have improved informed consent, have improved trust of their anesthesia providers, and be more satisfied with patient care. In addition, they anticipate that the care team also will benefit by the enhanced communication with the participant.

Interventions

  • BEHAVIORAL Extended translation
  • BEHAVIORAL Standard translation

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2023-02-14
Est. Completion 2023-06-12
Phase NA

What the Registry Record Tells You About NCT05502029

The ClinicalTrials.gov registry entry for NCT05502029 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Extended translation is the first listed.

NCT05502029 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05502029 about?

NCT05502029 is a clinical study titled "Translating Anesthesia Care Throughout". Patients with limited English proficiency (LEP) are at significant risk of receiving care different from those who are English proficient. Through Translating Anesthetic Care Throughout (TACT), the investigators aim to reduce the disparities experienced by participants with LEP undergoing anesthesia...

What is the current status of trial NCT05502029?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2023-02-14. Estimated completion is 2023-06-12.

What interventions are being tested in trial NCT05502029?

The interventions under investigation include: Extended translation (BEHAVIORAL), Standard translation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05502029?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.